Luis Gil Abinader is a fellow with the Global Health Policy and Politics Initiative.
Gil Abinader is interested in intellectual property, access to medicines, and the global governance of knowledge goods. His current research focuses on patent licensing, technology transfer, strengthening manufacturing capacity in low- and middle-income countries, and alternative models for incentivizing research and development.
Prior to Georgetown Law, Gil Abinader worked as a senior researcher at Knowledge Ecology International (KEI), a fellow with the Interdisciplinary Centre of Studies in Science, Technology and Innovation (CIECTI), and an adjunct professor at the Universidad Nacional General Sarmiento (UNGS) in Argentina. At KEI, Gil Abinader supported global campaigns fighting for affordable access to medical innovation. Gil Abinader has also worked with governments and other stakeholders to promote the use of international intellectual property flexibilities.
Gil Abinader currently serves at the Expert Advisory Group (EAG) of the Medicines Patent Pool (MPP) and on the Board of the Universities Allied for Essential Medicines (UAEM). He has been a consultant to several national governments and international organizations, including the World Health Organization. He has published several papers related to intellectual property.
Gil Abinader holds an LL.M. in Global Health Law from Georgetown University Law Center and a master’s in intellectual property from the Latin American Faculty of Social Sciences (FLACSO) in Argentina. His law degree was obtained at the Pontificia Universidad Católica Madre y Maestra (PUCMM) in the Dominican Republic.